Latest Virax Biolabs News & Updates

See the latest news and media coverage for Virax Biolabs. We track all announcements, press releases, and industry mentions in real time, all in one place.

Virax Biolabs

Immunology research company

viraxbiolabs.com

Headquarters: Motherwell, United Kingdom
Founded year: 2013
Company type: Public company
Number of employees: 30–50

Last updated Today

Latest news about Virax Biolabs

In short: Virax Biolabs focused on its ViraxImmune platform for post-acute infection syndromes and secured $5 million in private placement funding.

Company announcements

May 18 Virax Biolabs

Virax Biolabs expands Ebola immunology portfolio

It is developing a peptide pool for the Bundibugyo strain and offers one for the Zaire strain.

March 31 Virax Biolabs

Virax Biolabs achieved ISO 13485 and ISO 9001 certifications

The certifications support regulated IVD development and U.S. clinical validation for its PAIS strategy.

3 December 2025 Virax Biolabs

Virax Biolabs announces $5 million private placement

The offering of 12.5M shares at $0.40 each will provide working capital. H.C. Wainwright acted as placement agent.

3 November 2025 Virax Biolabs

Virax Biolabs completes UK recruitment and reports FDA feedback

The ViraxImmune assay targets T cell dysfunction in post-acute infection syndromes, with a US study planned for 2026.

Media coverage

May 23 The Globe and Mail

Virax Biolabs Calls June 5 EGM to Approve Reverse Share Split and Charter Amendments

Detailed price information for Virax Biolabs Group Limited (VRAX-Q) from The Globe and Mail including charting and trades.

May 19 MSN

Why is Virax Biolabs (VRAX) stock trending overnight?

Virax Biolabs Group Limited VRAX shares are trending on Tuesday. VRAX shares rose 17.36% to $0.28 in after-hours trading on Monday. The jump in the...

April 11 The Globe and Mail

Virax Biolabs Announces Full Exercise of Pre-Funded Warrants From $5 Million Private Placement

Detailed price information for Virax Biolabs Group Limited (VRAX-Q) from The Globe and Mail including charting and trades.

January 18 Benzinga

Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally - Virax Biolabs Group (NASDAQ:VRAX)

VRAX shares fell 12.79% in after-hours trading following a $5 million private placement announcement.

Never miss news about Virax Biolabs

Track Virax Biolabs and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Virax Biolabs competitors & trending companies

Browse news for competitors to Virax Biolabs and other trending companies.